Parathyroid Hormone–Related Peptide-Reference-Cited by-同舟云学术

Parathyroid Hormone–Related Peptide

Published:2017-04-12 Issue:6 Volume:22 Page:529-537
ISSN:1074-2484
Container-title:Journal of Cardiovascular Pharmacology and Therapeutics
language:en
Short-container-title:J Cardiovasc Pharmacol Ther

Author:

Datta Tanuka¹,Przyklenk Karin²³⁴,Datta Nabanita S.²⁵

Affiliation:

1. Department of Internal Medicine, George Washington University, Washington, DC, USA

2. Cardiovascular Research Institute, Wayne State University School of Medicine, Detroit, MI, USA

3. Department of Physiology, Wayne State University School of Medicine, Detroit, MI, USA

4. Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, MI, USA

5. Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, USA

Abstract

An as-yet limited body of evidence suggests that calcium-regulating endocrine hormones—in particular, parathyroid hormone–related peptide (PTHrP)—may have unappreciated cardioprotective effects. The current review focuses on the concept that PTHrP may, via modulation of classic cardioprotective signaling pathways, provide a novel strategy to attenuate myocardial ischemia–reperfusion injury.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1074248417702976

Reference114 articles.

1. Global and regional causes of death

2. Population Versus Clinical View of Case Fatality From Acute Coronary Heart Disease

3. Heart Disease and Stroke Statistics—2015 Update

4. Myocardial Reperfusion Injury

5. There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parathyroid Hormone-Related Peptide and Its Analog, Abaloparatide, Attenuate Lethal Myocardial Ischemia-Reperfusion Injury;Journal of Clinical Medicine;2022-04-19

2. Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?;Journal of Investigative Medicine;2021-05-05

3. Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial;The Journal of Clinical Endocrinology & Metabolism;2020-07-13